Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > RNAi Asia / Screening Asia 2010

Abstract:
15th-16th November 2010, Singapore

RNAi Asia / Screening Asia 2010

Singapore | Posted on August 18th, 2010

Select Biosciences is proud to announce their inaugural RNAi/Screening Asia Conference. This year's event will take place at the Matrix Building, Biopolis in Singapore.

Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day event, gathering some of the most influential players in the field from Asia and across the globe.

The agenda will include world leading research from renowned speakers including:

RNAi Asia

· John Mattick
Professor, University of Queensland

· Alan Sachs
Vice President, RNA Therapeutics, Merck Research Laboratories

· Dan Peer
Head, Laboratory of Nanomedicine, Tel Aviv University

· Shih-Peng Chan
Assistant Professor, National Taiwan University

Screening Asia

· Rathnam Chaguturu
Director, High Throughput Screening Laboratories, University of Kansas

· Paul Orange
Business Leader, Bio-Discovery, Perkin Elmer

· Hakim Djaballah
Director, Sloan-Kettering

· Sitta Sittampalam
Professor, University of Kansas

... and many more!

The full two day agenda includes the following sessions in RNAi Asia:

· Target Discovery and Validation
· Transfection
· siRNA Therapeutics
· in vivo RNAi
· siRNA library screens
· microRNAs

And in Screening Asia:

· High Content Screening
· Assay Development and Analysis
· Novel Screening Platforms and Technologies
· Screening and Drug Discovery
· Biosimilars & Biologics
· Natural Products Screening

To guarantee a high attendance at this exciting event Select Biosciences will maintain their traditional low registration fees and group booking discounts.

Full conference passes include admission to all sessions and the exhibition as well as conference documentation.

Lunch, coffee breaks and the drinks reception provide ample time for networking and to continue discussions from the question and answer sessions.

The conferences division of Select Biosciences Ltd. is focused on organizing specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.

For further information contact Kirit Shah,

####

For more information, please click here

Contacts:
Kirit Shah

Copyright © Select Biosciences

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Events/Classes

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Nanobiotechnology

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project